The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
Abstract
Although cancer classification has improved over the past 30 years, there has been no general approach for identifying new cancer classes (class discovery) or for assigning tumors to known classes (class prediction). Here, a generic approach to cancer classification based on gene expression monitoring by DNA microarrays is described and applied to human acute leukemias as a test case. A class discovery procedure automatically discovered the distinction between acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) without previous knowledge of these classes. An automatically derived class predictor was able to determine the class of new leukemia cases. The results demonstrate the feasibility of cancer classification based solely on gene expression monitoring and suggest a general strategy for discovering and predicting cancer classes for other types of cancer, independent of previous biological knowledge.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In fact, this approach has already been used to identify genes that could serve as molecular markers of cancer classification and outcome prediction (10-14).”
From Prediction of the response to chemotherapy in advanced esophageal cancer by gene expression profiling of biopsy samples (2010) · cites this paper as [10]
In the citing paper
“This model was evaluated by leave-one-out cross-validation, whereby one sample was withheld, a gene expression based model was trained using the remaining samples, and then the model was used to predict the class of the withheld sample (10).”
From Prediction of the response to chemotherapy in advanced esophageal cancer by gene expression profiling of biopsy samples (2010) · cites this paper as [10]
In the citing paper
“The transcription factor HoxA9 is overexpressed in 70% of AML cases, and overexpression of this transcription factor alone is sufficient to immortalize murine bone marrow derived myeloid cells (Ayton and Cleary, 2003; Golub et al., 1999; Kroon et al., 1998).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Golub et al., 1999
Citations
Cites
Spellman, P. T., Sherlock, G. J., Zhang, M. Q., Iyer, V. R., Anders, K. R., Eisen, M. B., Brown, P. O., Botstein, D., & Futcher, B. (1998) · Molecular Biology of the Cell · doi:10.1091/mbc.9.12.3273 · Cited by 4,724
Tissue microarrays for high-throughput molecular profiling of tumor specimens
Kononen, J., Bubendorf, L., Kallionimeni, A., Barlund, M. T., Schraml, P., Leighton, S. B., Torhorst, J. K. H., Mihatsch, M. J., Sauter, G., & Kallionimeni, O.-P. (1998) · Nature Medicine · doi:10.1038/nm0798-844 · Cited by 4,101
Tamayo, P., Slonim, D. K., Mesirov, J. P., Zhu, Q., Kitareewan, S., Dmitrovsky, E., Lander, E. S., & Golub, T. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.2907 · Cited by 2,924
Self-citationExpression monitoring by hybridization to high-density oligonucleotide arrays
Lockhart, D. J., Dong, H., Byrne, M. C., Follettie, M. T., Gallo, M. V., Chee, M. S., Mittmann, M., Wang, C., Kobayashi, M., Norton, H., et al. (1996) · Nature Biotechnology · doi:10.1038/nbt1296-1675 · Cited by 2,841
The Transcriptional Program in the Response of Human Fibroblasts to Serum
Iyer, V. R., Eisen, M. B., Ross, D. T., Schuler, G. D., Moore, T. A., Lee, J. C. F., Trent, J. M., Staudt, L. M., Hudson, J., Boguski, M. S., et al. (1999) · Science · doi:10.1126/science.283.5398.83 · Cited by 1,966
Use of a cDNA microarray to analyse gene expression patterns in human cancer
DeRisi, J. L., Penland, L., Brown, P. O., Bittner, M. L., Meltzer, P. S., Ray, M., Chen, Y.-W., Su, Y. A., & Trent, J. M. (1996) · Nature Genetics · doi:10.1038/ng1296-457 · Cited by 1,952
Farber, S., Diamond, L. K., Mercer, R. D., Sylvester, R. F., & Wolff, J. A. (1948) · New England Journal of Medicine · doi:10.1056/nejm194806032382301 · Cited by 1,806
Dalla‐Favera, R., Bregni, M., Erikson, J., Patterson, D., Gallo, R. C., & Croce, C. M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.24.7824 · Cited by 1,764
Parallel human genome analysis: microarray-based expression monitoring of 1000 genes.
Schena, M., Shalon, D., Heller, R. A., Chai, A., Brown, P. O., & Davis, R. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.10614 · Cited by 1,599
The New Genomics: Global Views of Biology
Lander, E. S. (1996) · Science · doi:10.1126/science.274.5287.536 · Cited by 1,174
Self-citationDelattre, O., Zucman‐Rossi, J., Melot, T., Sastre‐Garau, X., Zucker, J., Lenoir, G., Ambros, P. F., Sheer, D., Turc‐Carel, C., Triche, T. J., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408043310503 · Cited by 1,104
Genome-wide expression monitoring in Saccharomyces cerevisiae
Wodicka, L. M., Dong, H., Mittmann, M., Ho, M.-H., & Lockhart, D. J. (1997) · Nature Biotechnology · doi:10.1038/nbt1297-1359 · Cited by 973
Pui, C., & Evans, W. E. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808273390907 · Cited by 841
Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia.
Golub, T. R., Barker, G. F., Bohlander, S. K., Hiebert, S. W., Ward, D. C., Bray-Ward, P., Morgan, E., Raimondi, S. C., Rowley, J. D., & Gilliland, D. G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.4917 · Cited by 704
Self-citationHoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b
Kroon, E., Krosl, J., Thorsteinsdottir, U., Baban, S., Buchberg, A. M., & Sauvageau, G. (1998) · The EMBO Journal · doi:10.1093/emboj/17.13.3714 · Cited by 640
Shurtleff, S. A., Buijs, A., Behm, F. G., Rubnitz, J. E., Raimondi, S. C., Hancock, M. L., Chan, G., Pui, C., Grosveld, G. C., & Downing, J. R. (1995) · PubMed · Cited by 547
Self-citationCYTOCHEMICAL DEMONSTRATION OF PEROXIDASE ACTIVITY WITH 3-AMINO-9-ETHYLCARBAZOLE
Graham, R. C., Lundholm, U., & Karnovsky, M. J. (1965) · Journal of Histochemistry & Cytochemistry · doi:10.1177/13.2.150 · Cited by 541
Role of topoisomerase II in mediating epipodophyllotoxin-induced DNA cleavage.
Ross, W. E., Rowe, T., Glisson, B. S., Yalowich, J. C., & Liu, L. F. (1984) · PubMed · Cited by 459
Borrow, J., Shearman, A. M., Stanton, V. P., Becher, R., Collins, T., Williams, A. J., Dubé, I. D., Katz, F. E., Kwong, Y., Morris, C. M., et al. (1996) · Nature Genetics · doi:10.1038/ng0296-159 · Cited by 448
Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays.
Khan, J. I., Simon, R., Bittner, M. L., Chen, Y., Leighton, S. B., Pohida, T. J., Smith, P. D., Jiang, Y. Y., Gooden, G. C., Trent, J. M., et al. (1998) · PubMed · Cited by 437
High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia
Romana, S., Poirel, H., Leconiat, M., Flexor, M., Mauchauffe, M., Jonveaux, P., Macintyre, E., Berger, R., & Bernard, O. (1995) · Blood · doi:10.1182/blood.v86.11.4263.bloodjournal86114263 · Cited by 427
Identificaton of a translocation with quinacrine fluorescence in a patient with acute leukemia.
Rowley, J. D. (1973) · PubMed · Cited by 366
A specific chromosomal abnormality in rhabdomyosarcoma
Douglass, E. C., Valentine, M. C., Etcubanas, E., et al. (2008) · Cytogenetics and Cell Genetics · doi:10.1159/000132446 · Cited by 324
Distribution of Ia-like molecules on the surface of normal and leukemic human cells.
Schlossman, S. F., Chess, L., Humphreys, R. E., et al. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.4.1288 · Cited by 320
McLean, T., Ringold, S., Neuberg, D. S., Stegmaier, K., Tantravahi, R. V., Ritz, J., Koeffler, H., Takeuchi, S., Janssen, J. W. G., Seriu, T., et al. (1996) · Blood · doi:10.1182/blood.v88.11.4252.4252 · Cited by 319
Self-citationCombining SSH and cDNA microarrays for rapid identification of differentially expressed genes
Yang, G. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.6.1517 · Cited by 285
McLean, T., Ringold, S., Neuberg, D. S., et al. (1996) · Blood · doi:10.1182/blood.v88.11.4252.bloodjournal88114252 · Cited by 236
Consistent chromosomal translocation in alveolar rhabdomyosarcoma
Turc‐Carel, C., Lizard‐Nacol, S., Justrabo, E., et al. (1986) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(86)90069-5 · Cited by 229
Surface Markers and Prognostic Factors in Acute Lymphoblastic Leukemia
Tsukimoto, I., Wong, K. Y., & Lampkin, B. C. (1976) · New England Journal of Medicine · doi:10.1056/nejm197601292940503 · Cited by 229
Cell surface antigens: prognostic implications in childhood acute lymphoblastic leukemia
Sallan, S. E., Ritz, J., Pesando, J., et al. (1980) · Blood · doi:10.1182/blood.v55.3.395.395 · Cited by 228
Frei, E., Freireich, E. J., Gehan, E. A., et al. (1961) · Blood · doi:10.1182/blood.v18.4.431.431 · Cited by 226
Balaban-Malenbaum, G., & Gilbert, F. (1977) · Science · doi:10.1126/science.71759 · Cited by 201
FORKNER, C. E. (1938) · The American Journal of the Medical Sciences · doi:10.1097/00000441-193811000-00020 · Cited by 191
Konopleva, M. Y., Mikhail, A. A., Estrov, Z. E., Zhao, S., Harris, D., Sanchez‐Williams, G., Kornblau, S. M., Dong, J., Kliche, K. O., Jiang, S., et al. (1999) · Blood · doi:10.1182/blood.v93.5.1668 · Cited by 188
Purification and characterization of zyxin, an 82,000-dalton component of adherens junctions.
Crawford, A. W., & Beckerle, M. C. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)67675-1 · Cited by 174
The genetics of cancer—a 3D model
Cole, K. A., Krizman, D. B., & Emmert‐Buck, M. R. (1999) · Nature Genetics · doi:10.1038/4466 · Cited by 139
Monoclonal antibody characterization of surface antigens in childhood T- cell lymphoid malignancies
Röper, M., Crist, W., Metzgar, R. S., et al. (1983) · Blood · doi:10.1182/blood.v61.5.830.830 · Cited by 129
Cytogenetic and pathologic aspects of Ewing's sarcoma and neuroectodermal tumors
Stephenson, C. F., Bridge, J. A., & Sandberg, A. A. (1992) · Human Pathology · doi:10.1016/0046-8177(92)90295-e · Cited by 81
Konopleva, M. Y., Mikhail, A. A., Estrov, Z. E., et al. (1999) · Blood · doi:10.1182/blood.v93.5.1668.405a15_1668_1676 · Cited by 78
Leukemia-associated antigens in ALL
Pesando, J. M., Ritz, J., Lazarus, H., et al. (1979) · Blood · doi:10.1182/blood.v54.6.1240.1240 · Cited by 72
Observations on the periodic acid‐Schiff reaction in lymphoproliferative diseases
Quaglino, D., & Hayhoe, F. G. J. (1959) · The Journal of Pathology and Bacteriology · doi:10.1002/path.1700780219 · Cited by 57
mb-1: a new marker for B-lineage lymphoblastic leukemia
Buccheri, V., Mihaljević, B., Matutes, E., et al. (1993) · Blood · doi:10.1182/blood.v82.3.853.853 · Cited by 52
mb-1: a new marker for B-lineage lymphoblastic leukemia
Buccheri, V., Mihaljević, B., Matutes, E., et al. (1993) · Blood · doi:10.1182/blood.v82.3.853.bloodjournal823853 · Cited by 50
Treatment of the newly diagnosed adult with de novo acute myeloid leukemia.
Stone, R. M., & Mayer, R. J. (1993) · PubMed · Cited by 47
Bennett, J. M., & Dutcher, T. F. (1969) · Blood · doi:10.1182/blood.v33.2.341.341 · Cited by 39
Treatment of the Newly Diagnosed Adult with De Noyo Acute Myeloid Leukemia
Stone, R. M., & Mayer, R. J. (1993) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30257-0 · Cited by 34
Dinndorf, P. A., Buckley, J. D., Nesbit, M. E., et al. (1992) · Medical and Pediatric Oncology · doi:10.1002/mpo.2950200303 · Cited by 22
Adult acute myeloid leukaemia: update on treatment
Bishop, J. F. (1999) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1999.tb126866.x · Cited by 21
N-myc protein expression in small round cell tumors.
Tj, T., Cavazzana, A. O., Navarro, S., et al. (1988) · PubMed · Cited by 14
Diagnostic application of monoclonal antibody KB90 (CD11c) in acute myeloid leukaemia
Master, P. S., Richards, S. J., Kendall, J. C., et al. (1989) · Annals of Hematology · doi:10.1007/bf00320851 · Cited by 8
Hansen, K. H., Lukas, J., Holm, K., Kjerulff, A. A., & Bártek, J. (1999) · Electrophoresis · doi:10.1002/(sici)1522-2683(19990201)20:2 · Cited by 8
Research works printed but not linked: 14
- Triche T. J., et al., Prog. Clin. Biol. Res. 271, 475 (1988).
- Shurtleff S. A., et al., Leukemia 9, 1985 (1995);
- Rowley J. D., Ann. Genet. 16, 109 (1973) .
- 10.1038/ng1296-457 · DOI
- Khan J., et al., Cancer Res. 58, 5009 (1998);
- 10.1038/ng1296-457 · DOI
- Yang G. P., Ross D. T., Kuang W. W., Brown P. O., Weigel R. J., Nucleic Acids Res. 27, 1517 (1999); · DOI
- Khan J., et al., Cancer Res. 58, 5009 (1998);
- 10.1038/nbt1297-1359 · DOI
- Each gene is represented by an expression vector v ( g ) = ( e 1 e 2 … e n ) where e i denotes the expression level of gene g in i th sample in the initial set S of samples. A class distinction is represented by an idealized expression pattern c = ( c 1 c 2 … c n ) where c i = +1 or 0 according to whether the i -th sample belongs to class 1 or class 2. One can measure “correlation” between a gene and a class distinction in a variety of ways. One can use the Pearson correlation coefficient or the Euclidean distance. We used a measure of correlation P ( g c ) that emphasizes the “signal-to-noise” ratio in using the gene as a predictor. Let [μ 1 ( g ) σ 1 ( g )] and [μ 2 ( g ) σ 2 ( g )] denote the means and SDs of the log of the expression levels of gene g for the samples in class 1 and class 2 respectively. Let P ( g c ) = [μ 1 ( g ) − μ 2 ( g )]/[σ 1 ( g ) + σ 2 ( g )] which reflects the difference between the classes relative to the SD within the classes. Large values of | P ( g c )| indicate a strong correlation between the gene expression and the class distinction while the sign of P ( g c ) being positive or negative corresponds to g being more highly expressed in class 1 or class 2. Unlike a standard Pearson correlation coefficient P ( g c ) is not confined to the range [–1 +1]. Neighborhoods N 1 ( c r ) and N 2 ( c r ) of radius r around class 1 and class 2 were defined to be the sets of genes such that P ( g c ) = r and P ( g c ) = − r respectively. An unusually large number of genes within the neighborhoods indicates that many genes have expression patterns closely correlated with the class vector.
- Ross W., Rowe T., Glisson B., Yalowich J., Liu L., Cancer Res. 44, 5857 (1984).
- 10.1073/pnas.96.6.2907 · DOI
- Turc-Carel S., et al., Cancer Genet. Cytogenet. 19, 361 (1986); · DOI
- Douglass E. C. et al. 45 148 (1987). · DOI
Cited by
Sorted by citations
Metagenomic biomarker discovery and explanation
Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S., & Huttenhower, C. (2011) · Genome Biology · doi:10.1186/gb-2011-12-6-r60 · Cited by 16,192
Why Most Published Research Findings Are False
Ioannidis, J. P. A. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020124 · Cited by 10,505
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Self-citationDistinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., et al. (2000) · Nature · doi:10.1038/35000501 · Cited by 9,925
Gene selection for cancer classification using support vector machines
Guyon, I., Weston, J., Barnhill, S., & Vapnik, V. (2002) · Machine Learning · doi:10.1023/a:1012487302797 · Cited by 9,954
Metadata
- Authors
- Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., Bloomfield, C. D., & Lander, E. S.
- Affiliations
- Harvard University (US)
- Massachusetts Institute of Technology (US)
- St. Jude Children's Research Hospital (US)
- The Ohio State University (US)
- Corresponding author
- Golub, T. R.
- Slonim, D. K.
- Lander, E. S.
- ORCID
- Venue
- Science
- Published
- 1999-10-15
- Volume
- 286
- Issue
- 5439
- Pages
- 531-537
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2109363337
- Cited by
- 11,516
- References
- 51
- Citations by year
- 2026: 81 · 2025: 152 · 2024: 150 · 2023: 247 · 2022: 216 · 2021: 262 · 2020: 275 · 2019: 329 · 2018: 309 · 2017: 322 · 2016: 332 · 2015: 398 · 2014: 451 · 2013: 468 · 2012: 522
- FWCI
- 108.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Health Sciences › Medicine › Hematology › Acute Lymphoblastic Leukemia research
- Keywords
- cancer classification, molecular classification, gene expression profiling, DNA microarrays, class discovery, class prediction, acute leukemia, acute myeloid leukemia, acute lymphoblastic leukemia, leukemia subtypes
- MeSH terms
- Acute Disease, Antineoplastic Combined Chemotherapy Protocols, Cell Adhesion, Cell Cycle, Humans, Leukemia, Myeloid, Neoplasm Proteins, Neoplasms, Oncogenes, Predictive Value of Tests, Reproducibility of Results, Treatment Outcome, Homeodomain Proteins, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Precursor Cell Lymphoblastic Leukemia-Lymphoma
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review